All posts by: Michael Zand

About Michael Zand

Ginkgo Bioworks Pulls In $275M as Synthetic Biology Funding Soars – Xconomy

Continue reading

2017-12-14 NEWS

Xconomy

Ginkgo Bioworks Pulls In $275M as Synthetic Biology Funding Soars
Xconomy
Companies sometimes raise big venture capital rounds to invest in equipment, people, and other tools for growth. Other times they do it to provide the business a cash cushion. And sometimes it’s about giving potential customers and partners more
The Latest “Unicorn” Genetically Engineers Everything From Perfume To FoodBuzzFeed News
Ginkgo Bioworks Launches New Organism Foundry, Supported by $275 Million in Series D FundingPR Newswire (press release)
Ginkgo Bioworks raises $275 million to bring its lab-made DNA to more industriesVentureBeat

all 8 news articles »

Continue reading

2017-12-14 NEWS

Xconomy

Ginkgo Bioworks Pulls In $275M as Synthetic Biology Funding Soars
Xconomy
Companies sometimes raise big venture capital rounds to invest in equipment, people, and other tools for growth. Other times they do it to provide the business a cash cushion. And sometimes it’s about giving potential customers and partners more
The Latest “Unicorn” Genetically Engineers Everything From Perfume To FoodBuzzFeed News
Ginkgo Bioworks Launches New Organism Foundry, Supported by $275 Million in Series D FundingPR Newswire (press release)
Ginkgo Bioworks raises $275 million to bring its lab-made DNA to more industriesVentureBeat

all 8 news articles »

Continue reading

2017-12-14 NEWS

Labiotech.eu (blog)

German Biotech’s Gene Therapy for Osteoarthritis Plucked by US Pharma
Labiotech.eu (blog)
GeneQuine’s gene therapy for osteoarthritis in the knee has been acquired by US pharma company Flexion Therapeutics for up to $64M. GeneQuine is developing a gene therapy for the treatment of osteoarthritis. It uses helper-dependent adenoviruses, which